Patent · US Active

Compositions and methods for detecting HEV nucleic acid

US10053742B2 · kind B2 · utility

1Cited by
3References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 14, 2014
Grant dateAug 21, 2018
Priority date
Expiry dateJan 17, 2035

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Disclosed are nucleic acid oligomers, including amplification oligomers, capture probes, and detection probes, for detection of Hepatitis E Virus (HEV) nucleic acid. Also disclosed are methods of specific nucleic acid amplification and detection using the disclosed oligomers, as well as corresponding reaction mixtures and kits.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.